314 related articles for article (PubMed ID: 34688807)
21. Delivery of re-irradiation and complex palliative radiotherapy using proton therapy in pediatric cancer patients.
Berlin E; Eisenberg R; Hill-Kayser C; Lustig RA; Kurtz G; Cummings E; LaRiviere M
Pediatr Blood Cancer; 2023 Dec; 70(12):e30708. PubMed ID: 37794575
[TBL] [Abstract][Full Text] [Related]
22. Reirradiation with advanced brachytherapy techniques in recurrent GYN cancers.
Mahantshetty U; Kashid SR; Mulye G; Gurram L; Engineer R; Chopra S; Ghosh J; Gulia S; Gupta S; Ghadi Y; A D; Kohle S; Kadam S; Menon S; Deodhar K; Maheshwari A; Ts S; Lewis S; Kalyani N; Shrivastava SK
Brachytherapy; 2023; 22(6):753-760. PubMed ID: 37716821
[TBL] [Abstract][Full Text] [Related]
23. Reirradiation of Recurrent and Second Primary Head and Neck Cancer With Proton Therapy.
McDonald MW; Zolali-Meybodi O; Lehnert SJ; Estabrook NC; Liu Y; Cohen-Gadol AA; Moore MG
Int J Radiat Oncol Biol Phys; 2016 Nov; 96(4):808-819. PubMed ID: 27788954
[TBL] [Abstract][Full Text] [Related]
24. Toxicities and Locoregional Control After External Beam Chest Wall and/or Regional Lymph Node Re-irradiation for Recurrent Breast Cancer.
Sayan M; Vergalasova I; Jan I; Kumar S; Chan N; Haffty BG; Ohri N
Anticancer Res; 2022 Jan; 42(1):93-96. PubMed ID: 34969713
[TBL] [Abstract][Full Text] [Related]
25. Early toxicity in patients treated with postoperative proton therapy for locally advanced breast cancer.
Cuaron JJ; Chon B; Tsai H; Goenka A; DeBlois D; Ho A; Powell S; Hug E; Cahlon O
Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):284-91. PubMed ID: 25754632
[TBL] [Abstract][Full Text] [Related]
26. Proton Reirradiation for High-Risk Recurrent or New Primary Breast Cancer.
Chakraborty MA; Khan AJ; Cahlon O; Xu AJ; Braunstein LZ; Powell SN; Choi JI
Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136268
[TBL] [Abstract][Full Text] [Related]
27. Reirradiation of recurrent breast cancer with and without concurrent chemotherapy.
Würschmidt F; Dahle J; Petersen C; Wenzel C; Kretschmer M; Bastian C
Radiat Oncol; 2008 Sep; 3():28. PubMed ID: 18801165
[TBL] [Abstract][Full Text] [Related]
28. Clinical Outcomes of Recurrent Intracranial Meningiomas Treated with Proton Beam Reirradiation.
Imber BS; Neal B; Casey DL; Darwish H; Lin AL; Cahlon O; Chon B; Tsai H; Hug E; Yamada Y; Yang TJ
Int J Part Ther; 2019; 5(4):11-22. PubMed ID: 31773037
[TBL] [Abstract][Full Text] [Related]
29. Clinical results of proton therapy reirradiation for recurrent nasopharyngeal carcinoma.
Dionisi F; Croci S; Giacomelli I; Cianchetti M; Caldara A; Bertolin M; Vanoni V; Pertile R; Widesott L; Farace P; Schwarz M; Amichetti M
Acta Oncol; 2019 Sep; 58(9):1238-1245. PubMed ID: 31155998
[No Abstract] [Full Text] [Related]
30. Rib fractures after reirradiation plus hyperthermia for recurrent breast cancer: Predictive factors.
Oldenborg S; Valk C; van Os R; Oei B; Venselaar J; Vörding PZ; van Randen A; Crezee H; van Tienhoven G; Rasch C
Strahlenther Onkol; 2016 Apr; 192(4):240-7. PubMed ID: 26856858
[TBL] [Abstract][Full Text] [Related]
31. Proton Beam Therapy in the Reirradiation Setting of Brain and Base of Skull Tumour Recurrences.
Gaito S; Burnet NG; Aznar MC; Marvaso G; Jereczek-Fossa BA; Crellin A; Indelicato D; Pan S; Colaco R; Rieu R; Smith E; Whitfield G
Clin Oncol (R Coll Radiol); 2023 Oct; 35(10):673-681. PubMed ID: 37574418
[TBL] [Abstract][Full Text] [Related]
32. Clinical Outcomes in Patients with Recurrent Glioblastoma Treated with Proton Beam Therapy Reirradiation: Analysis of the Multi-Institutional Proton Collaborative Group Registry.
Saeed AM; Khairnar R; Sharma AM; Larson GL; Tsai HK; Wang CJ; Halasz LM; Chinnaiyan P; Vargas CE; Mishra MV
Adv Radiat Oncol; 2020; 5(5):978-983. PubMed ID: 33083661
[TBL] [Abstract][Full Text] [Related]
33. A Multi-Institutional Experience of Proton Beam Therapy for Sinonasal Tumors.
Yu NY; Gamez ME; Hartsell WF; Tsai HK; Laramore GE; Larson GL; Simone CB; Rossi C; Katz SR; Buras MR; Golafshar MA; Vargas CE; Patel SH
Adv Radiat Oncol; 2019; 4(4):689-698. PubMed ID: 31673662
[TBL] [Abstract][Full Text] [Related]
34. Proton Reirradiation for Locoregionally Recurrent Breast Cancer.
LaRiviere MJ; Dreyfuss A; Taunk NK; Freedman GM
Adv Radiat Oncol; 2021; 6(4):100710. PubMed ID: 34409209
[TBL] [Abstract][Full Text] [Related]
35. Dosimetric Factors and Toxicity in Highly Conformal Thoracic Reirradiation.
Binkley MS; Hiniker SM; Chaudhuri A; Maxim PG; Diehn M; Loo BW; Shultz DB
Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):808-15. PubMed ID: 26831903
[TBL] [Abstract][Full Text] [Related]
36. Hyperthermia and reirradiation for locoregional recurrences in preirradiated breast cancers: a single institutional experience.
Datta NR; Puric E; Heüberger J; Marder D; Lomax N; Timm O; Memminger P; Bodis S
Swiss Med Wkly; 2015; 145():w14133. PubMed ID: 25906357
[TBL] [Abstract][Full Text] [Related]
37. Curative high-dose reirradiation for patients with recurrent head and neck squamous cell carcinoma using IMRT or proton therapy: Outcomes and analysis of patterns of failure.
Beddok A; Saint-Martin C; Krhili S; Eddine CA; Champion L; Chilles A; Goudjil F; Zefkili S; Amessis M; Peurien D; Choussy O; le Tourneau C; Dendale R; Buvat I; Créhange G; Calugaru V
Head Neck; 2022 Nov; 44(11):2452-2464. PubMed ID: 35875934
[TBL] [Abstract][Full Text] [Related]
38. Radiation and subsequent reirradiation outcomes in the treatment of diffuse intrinsic pontine glioma and a systematic review of the reirradiation literature.
Freese C; Takiar V; Fouladi M; DeWire M; Breneman J; Pater L
Pract Radiat Oncol; 2017; 7(2):86-92. PubMed ID: 28274399
[TBL] [Abstract][Full Text] [Related]
39. Clinical Outcomes of Patients With Recurrent Lung Cancer Reirradiated With Proton Therapy on the Proton Collaborative Group and University of Florida Proton Therapy Institute Prospective Registry Studies.
Badiyan SN; Rutenberg MS; Hoppe BS; Mohindra P; Larson G; Hartsell WF; Tsai H; Zeng J; Rengan R; Glass E; Katz S; Vargas C; Feigenberg SJ; Simone CB
Pract Radiat Oncol; 2019; 9(4):280-288. PubMed ID: 30802618
[TBL] [Abstract][Full Text] [Related]
40. Reirradiation for locoregionally recurrent non-small cell lung cancer.
Vyfhuis MAL; Rice S; Remick J; Mossahebi S; Badiyan S; Mohindra P; Simone CB
J Thorac Dis; 2018 Aug; 10(Suppl 21):S2522-S2536. PubMed ID: 30206496
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
